To examine the molecular mechanisms by which mitochondria contribute to tumor radioresistance and discuss emerging mitochondria-targeted therapeutic strategies, emphasizing the significance of overcoming radioresistance.
Key Findings:
Mitochondria play a critical role in radioresistance through metabolic adaptations and enhanced DNA repair mechanisms.
Dysregulation of apoptotic pathways, particularly Bcl-2 family proteins, facilitates evasion of radiation-induced cell death.
Mitochondrial-targeted therapies have potential to improve radiosensitivity in resistant malignancies, highlighting the urgency of addressing this issue.
Interpretation:
Mitochondria represent actionable therapeutic vulnerabilities in overcoming radioresistance in cancer treatment, with significant clinical implications.
Limitations:
The review primarily discusses preclinical and clinical evidence without extensive data on long-term outcomes.
Further research is needed to validate the efficacy of mitochondria-targeted therapies in diverse cancer types, particularly in specific malignancies.
Conclusion:
Mitochondrial-targeted radiosensitization strategies may enhance treatment outcomes in radioresistant tumors, underscoring the need for urgent action.
